Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biktarvy Test&Treat strategy for new HIV diagnosis
NCT04416906Phase 3Completed
- Sponsor
- Judit Pich Martínez
- Start
- Oct 2020
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bictegravir + emtricitabine + tenofovir alafenamide in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Judit Pich Martínez. Started Oct 2020; status: completed.
02
Drugs
bictegravir + emtricitabine + tenofovir alafenamide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT04416906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04416906.